Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukodystrophy, Metachromatic | 20 | 2022 | 45 | 6.820 |
Why?
|
Lysosomal Storage Diseases | 9 | 2022 | 78 | 3.560 |
Why?
|
Cerebroside-Sulfatase | 9 | 2022 | 15 | 2.520 |
Why?
|
Hematopoietic Stem Cell Transplantation | 34 | 2022 | 5128 | 2.310 |
Why?
|
Lentivirus | 16 | 2022 | 534 | 2.310 |
Why?
|
Hematopoietic Stem Cells | 18 | 2019 | 3387 | 2.160 |
Why?
|
Mucopolysaccharidosis I | 6 | 2022 | 51 | 1.660 |
Why?
|
Microglia | 9 | 2019 | 1161 | 1.560 |
Why?
|
Adrenoleukodystrophy | 5 | 2020 | 113 | 1.450 |
Why?
|
Genetic Vectors | 19 | 2022 | 3525 | 1.380 |
Why?
|
Iduronidase | 4 | 2020 | 30 | 1.270 |
Why?
|
Metallothionein | 2 | 2018 | 63 | 1.170 |
Why?
|
Galactosylceramidase | 5 | 2015 | 27 | 1.070 |
Why?
|
Wiskott-Aldrich Syndrome | 3 | 2022 | 131 | 1.060 |
Why?
|
Leukodystrophy, Globoid Cell | 6 | 2019 | 39 | 1.020 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 2 | 2019 | 139 | 0.860 |
Why?
|
Lysosomal Storage Diseases, Nervous System | 2 | 2012 | 8 | 0.840 |
Why?
|
beta-Thalassemia | 5 | 2019 | 247 | 0.830 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2020 | 43 | 0.780 |
Why?
|
Gangliosidoses | 1 | 2019 | 9 | 0.760 |
Why?
|
Mucopolysaccharidoses | 1 | 2019 | 27 | 0.750 |
Why?
|
Hematology | 2 | 2021 | 198 | 0.680 |
Why?
|
Homocystinuria | 1 | 2018 | 63 | 0.670 |
Why?
|
Italy | 8 | 2022 | 805 | 0.660 |
Why?
|
Blood Component Removal | 1 | 2018 | 118 | 0.650 |
Why?
|
Anemia, Sickle Cell | 4 | 2020 | 976 | 0.650 |
Why?
|
Coronavirus | 1 | 2020 | 148 | 0.650 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2018 | 220 | 0.640 |
Why?
|
Stem Cell Niche | 2 | 2011 | 332 | 0.640 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 268 | 0.630 |
Why?
|
Hydrolases | 1 | 2017 | 137 | 0.590 |
Why?
|
Transduction, Genetic | 7 | 2019 | 964 | 0.590 |
Why?
|
Brain Damage, Chronic | 1 | 2017 | 263 | 0.580 |
Why?
|
Saposins | 1 | 2015 | 27 | 0.570 |
Why?
|
Central Nervous System | 3 | 2019 | 1292 | 0.560 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2015 | 25 | 0.550 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2015 | 21 | 0.550 |
Why?
|
Leukemia | 2 | 2022 | 1514 | 0.550 |
Why?
|
Cerebral Ventricles | 1 | 2017 | 541 | 0.540 |
Why?
|
Gene Transfer Techniques | 6 | 2019 | 1282 | 0.530 |
Why?
|
Metabolic Diseases | 2 | 2020 | 649 | 0.520 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 374 | 0.490 |
Why?
|
Polymers | 1 | 2019 | 1613 | 0.420 |
Why?
|
Molecular Dynamics Simulation | 1 | 2014 | 361 | 0.420 |
Why?
|
Regenerative Medicine | 1 | 2015 | 300 | 0.420 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 994 | 0.400 |
Why?
|
Transplantation Conditioning | 3 | 2019 | 1567 | 0.390 |
Why?
|
Nanoparticles | 2 | 2019 | 1899 | 0.390 |
Why?
|
Nervous System Diseases | 2 | 2017 | 1647 | 0.340 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2021 | 175 | 0.330 |
Why?
|
Animals | 37 | 2020 | 169173 | 0.320 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 2 | 2022 | 160 | 0.320 |
Why?
|
Isoquinolines | 1 | 2009 | 380 | 0.320 |
Why?
|
Transgenes | 3 | 2019 | 1011 | 0.310 |
Why?
|
Immunotherapy, Adoptive | 1 | 2015 | 1023 | 0.310 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1726 | 0.310 |
Why?
|
Mice | 28 | 2019 | 80270 | 0.300 |
Why?
|
Mice, Inbred C57BL | 12 | 2019 | 22636 | 0.300 |
Why?
|
Bone Marrow | 3 | 2020 | 2922 | 0.300 |
Why?
|
Humans | 83 | 2023 | 715594 | 0.300 |
Why?
|
Natural Killer T-Cells | 1 | 2009 | 314 | 0.290 |
Why?
|
Mental Health | 1 | 2020 | 2681 | 0.290 |
Why?
|
Antigens, CD34 | 4 | 2019 | 663 | 0.290 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18175 | 0.290 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2168 | 0.280 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2720 | 0.280 |
Why?
|
Regeneration | 1 | 2015 | 1528 | 0.280 |
Why?
|
Anxiety | 1 | 2020 | 3912 | 0.280 |
Why?
|
Flow Cytometry | 5 | 2019 | 6092 | 0.270 |
Why?
|
Child | 30 | 2023 | 74413 | 0.270 |
Why?
|
Mice, Knockout | 13 | 2019 | 15040 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3166 | 0.270 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3283 | 0.270 |
Why?
|
Receptors, GABA-A | 1 | 2009 | 625 | 0.260 |
Why?
|
Central Nervous System Diseases | 1 | 2009 | 530 | 0.260 |
Why?
|
Virus Integration | 4 | 2019 | 300 | 0.260 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1589 | 0.260 |
Why?
|
Enzyme Replacement Therapy | 3 | 2022 | 81 | 0.250 |
Why?
|
Communicable Diseases | 2 | 2022 | 800 | 0.250 |
Why?
|
Pandemics | 2 | 2020 | 7306 | 0.250 |
Why?
|
gamma-Globins | 2 | 2020 | 92 | 0.230 |
Why?
|
Immunophenotyping | 3 | 2021 | 1894 | 0.230 |
Why?
|
Cyclosporine | 2 | 2019 | 816 | 0.220 |
Why?
|
Interleukin-7 | 1 | 2022 | 144 | 0.210 |
Why?
|
Histiocytosis | 1 | 2021 | 38 | 0.210 |
Why?
|
Agammaglobulinemia | 1 | 2022 | 177 | 0.210 |
Why?
|
Paramyxoviridae Infections | 1 | 2021 | 58 | 0.210 |
Why?
|
Sulfoglycosphingolipids | 2 | 2013 | 17 | 0.210 |
Why?
|
B-Lymphocyte Subsets | 1 | 2022 | 252 | 0.210 |
Why?
|
Adenoviridae Infections | 1 | 2021 | 104 | 0.200 |
Why?
|
Cell Differentiation | 7 | 2015 | 11644 | 0.200 |
Why?
|
Fetal Hemoglobin | 2 | 2020 | 333 | 0.200 |
Why?
|
Familial Mediterranean Fever | 1 | 2021 | 67 | 0.200 |
Why?
|
Histiocytic Sarcoma | 1 | 2021 | 46 | 0.200 |
Why?
|
Macrophage Activation Syndrome | 1 | 2021 | 100 | 0.200 |
Why?
|
Nephrocalcinosis | 1 | 2020 | 61 | 0.200 |
Why?
|
Depression | 1 | 2020 | 7266 | 0.190 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2020 | 77 | 0.190 |
Why?
|
Green Fluorescent Proteins | 3 | 2017 | 2180 | 0.190 |
Why?
|
In Situ Nick-End Labeling | 2 | 2012 | 662 | 0.190 |
Why?
|
Comparative Genomic Hybridization | 1 | 2021 | 515 | 0.190 |
Why?
|
Reed-Sternberg Cells | 1 | 2020 | 82 | 0.190 |
Why?
|
Mutation | 5 | 2022 | 29253 | 0.190 |
Why?
|
Brain | 10 | 2021 | 25189 | 0.190 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9838 | 0.180 |
Why?
|
Genetic Engineering | 2 | 2017 | 943 | 0.180 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 165 | 0.180 |
Why?
|
Sulfatases | 2 | 2010 | 41 | 0.180 |
Why?
|
Neonatal Screening | 2 | 2020 | 559 | 0.180 |
Why?
|
Mucormycosis | 1 | 2019 | 89 | 0.180 |
Why?
|
Quality of Life | 1 | 2020 | 11736 | 0.170 |
Why?
|
Busulfan | 2 | 2009 | 271 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2021 | 364 | 0.170 |
Why?
|
MicroRNAs | 3 | 2021 | 3618 | 0.170 |
Why?
|
Glycosaminoglycans | 1 | 2020 | 602 | 0.160 |
Why?
|
Hydrazones | 1 | 2018 | 105 | 0.160 |
Why?
|
Benzylamines | 1 | 2018 | 224 | 0.160 |
Why?
|
Hypercalcemia | 1 | 2020 | 427 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 436 | 0.160 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 553 | 0.150 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 660 | 0.150 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 275 | 0.150 |
Why?
|
Cell Separation | 3 | 2019 | 1818 | 0.150 |
Why?
|
Polyesters | 1 | 2018 | 367 | 0.150 |
Why?
|
Gene Expression | 4 | 2017 | 7944 | 0.150 |
Why?
|
Exosomes | 1 | 2021 | 402 | 0.150 |
Why?
|
Prodrugs | 1 | 2018 | 273 | 0.150 |
Why?
|
Cerebrospinal Fluid | 1 | 2019 | 552 | 0.140 |
Why?
|
Hematopoiesis | 2 | 2019 | 1989 | 0.140 |
Why?
|
Coculture Techniques | 3 | 2017 | 1351 | 0.140 |
Why?
|
Vitamin B 12 | 1 | 2018 | 512 | 0.140 |
Why?
|
Growth Disorders | 1 | 2020 | 656 | 0.140 |
Why?
|
Neoplasms | 2 | 2021 | 20515 | 0.140 |
Why?
|
Adolescent | 14 | 2021 | 85064 | 0.140 |
Why?
|
Rare Diseases | 1 | 2019 | 529 | 0.130 |
Why?
|
Thrombocytopenia | 1 | 2022 | 1144 | 0.130 |
Why?
|
China | 1 | 2020 | 2234 | 0.130 |
Why?
|
Dependovirus | 1 | 2019 | 731 | 0.130 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4490 | 0.130 |
Why?
|
Alleles | 3 | 2015 | 7095 | 0.120 |
Why?
|
Biotechnology | 1 | 2016 | 279 | 0.120 |
Why?
|
Spinal Cord | 2 | 2019 | 1807 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2021 | 1179 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1019 | 0.120 |
Why?
|
Age of Onset | 2 | 2022 | 3312 | 0.120 |
Why?
|
Child, Preschool | 11 | 2022 | 41184 | 0.120 |
Why?
|
Infant | 8 | 2021 | 34561 | 0.120 |
Why?
|
Lymphoma, B-Cell | 1 | 2020 | 932 | 0.120 |
Why?
|
Genotype | 3 | 2015 | 12929 | 0.120 |
Why?
|
Cell Tracking | 1 | 2014 | 147 | 0.120 |
Why?
|
Gliosis | 2 | 2015 | 236 | 0.120 |
Why?
|
Myeloid Cells | 1 | 2017 | 778 | 0.120 |
Why?
|
Databases, Genetic | 2 | 2021 | 1800 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2016 | 484 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1723 | 0.110 |
Why?
|
Fluorescent Dyes | 1 | 2020 | 1969 | 0.110 |
Why?
|
Phenotype | 4 | 2021 | 16302 | 0.110 |
Why?
|
Visual Cortex | 1 | 2020 | 1139 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 34429 | 0.110 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 319 | 0.110 |
Why?
|
Dextrans | 1 | 2014 | 615 | 0.110 |
Why?
|
Repressor Proteins | 2 | 2020 | 3064 | 0.110 |
Why?
|
Lysosomes | 1 | 2017 | 893 | 0.110 |
Why?
|
Hodgkin Disease | 1 | 2020 | 1437 | 0.110 |
Why?
|
Aorta | 1 | 2019 | 2071 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2010 | 258 | 0.110 |
Why?
|
RNA Interference | 1 | 2020 | 2975 | 0.100 |
Why?
|
Doxorubicin | 1 | 2018 | 2218 | 0.100 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2011 | 85 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1255 | 0.100 |
Why?
|
Enzymes | 1 | 2012 | 266 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 2544 | 0.100 |
Why?
|
Male | 25 | 2022 | 350143 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1460 | 0.100 |
Why?
|
Bone Marrow Cells | 3 | 2019 | 2560 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1268 | 0.100 |
Why?
|
Female | 25 | 2022 | 377052 | 0.100 |
Why?
|
Cells, Cultured | 8 | 2019 | 19892 | 0.100 |
Why?
|
Multiple Sulfatase Deficiency Disease | 1 | 2009 | 2 | 0.100 |
Why?
|
Sandhoff Disease | 1 | 2009 | 13 | 0.100 |
Why?
|
Cell Line | 4 | 2019 | 16559 | 0.100 |
Why?
|
U937 Cells | 1 | 2010 | 275 | 0.090 |
Why?
|
Myelin Sheath | 2 | 2015 | 647 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 7983 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1693 | 0.090 |
Why?
|
Hemoglobinopathies | 1 | 2010 | 101 | 0.090 |
Why?
|
Image Enhancement | 1 | 2020 | 2977 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 11192 | 0.090 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2009 | 74 | 0.090 |
Why?
|
Enterococcus faecium | 1 | 2010 | 109 | 0.090 |
Why?
|
Pilot Projects | 2 | 2020 | 8079 | 0.090 |
Why?
|
Spleen | 2 | 2019 | 2458 | 0.090 |
Why?
|
Sphingolipids | 1 | 2010 | 168 | 0.090 |
Why?
|
Polydeoxyribonucleotides | 1 | 2009 | 120 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2021 | 24776 | 0.090 |
Why?
|
Schwann Cells | 1 | 2009 | 204 | 0.090 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4830 | 0.080 |
Why?
|
Transplantation Chimera | 1 | 2011 | 622 | 0.080 |
Why?
|
HeLa Cells | 3 | 2009 | 3211 | 0.080 |
Why?
|
beta-Galactosidase | 1 | 2009 | 610 | 0.080 |
Why?
|
Carbon Radioisotopes | 1 | 2009 | 612 | 0.080 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2009 | 220 | 0.080 |
Why?
|
Bone Marrow Transplantation | 2 | 2015 | 2763 | 0.080 |
Why?
|
Genetic Testing | 1 | 2020 | 3347 | 0.080 |
Why?
|
Macrophages | 2 | 2019 | 5746 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2213 | 0.080 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2010 | 342 | 0.080 |
Why?
|
Contrast Media | 1 | 2020 | 5275 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3738 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2286 | 0.080 |
Why?
|
Heterozygote | 1 | 2013 | 2792 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 1932 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2009 | 1907 | 0.070 |
Why?
|
Demyelinating Diseases | 1 | 2009 | 365 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2956 | 0.070 |
Why?
|
Cell Movement | 2 | 2012 | 5387 | 0.070 |
Why?
|
Blood-Brain Barrier | 1 | 2012 | 1002 | 0.070 |
Why?
|
Neurophysiology | 1 | 2006 | 102 | 0.070 |
Why?
|
Pyrroles | 2 | 2010 | 1172 | 0.070 |
Why?
|
Glioblastoma | 1 | 2020 | 3345 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4264 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2022 | 62039 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10660 | 0.070 |
Why?
|
Colony-Forming Units Assay | 2 | 2019 | 368 | 0.070 |
Why?
|
Cell Count | 1 | 2009 | 1910 | 0.070 |
Why?
|
Microscopy, Confocal | 2 | 2009 | 2030 | 0.070 |
Why?
|
Antiviral Agents | 3 | 2023 | 2807 | 0.070 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2010 | 590 | 0.070 |
Why?
|
Fatal Outcome | 3 | 2021 | 1878 | 0.070 |
Why?
|
Cell Survival | 2 | 2018 | 6028 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11664 | 0.070 |
Why?
|
Remission Induction | 1 | 2010 | 2392 | 0.070 |
Why?
|
Thymus Gland | 1 | 2009 | 1317 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2010 | 1195 | 0.060 |
Why?
|
Viruses | 1 | 2008 | 357 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2645 | 0.060 |
Why?
|
Fibroblast Growth Factors | 1 | 2010 | 883 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39334 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6500 | 0.060 |
Why?
|
DNA Damage | 1 | 2013 | 2429 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2011 | 950 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18772 | 0.060 |
Why?
|
Immunosuppressive Agents | 3 | 2010 | 4192 | 0.060 |
Why?
|
Enzyme Activation | 3 | 2015 | 3815 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 2030 | 0.050 |
Why?
|
Ligands | 1 | 2009 | 3286 | 0.050 |
Why?
|
Transfection | 1 | 2010 | 6081 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2019 | 5098 | 0.050 |
Why?
|
Lymphocytes | 1 | 2009 | 2734 | 0.050 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 164 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 435 | 0.050 |
Why?
|
Apoptosis | 3 | 2015 | 9960 | 0.050 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1690 | 0.050 |
Why?
|
Nervous System | 1 | 2004 | 565 | 0.050 |
Why?
|
Cytosine | 1 | 2021 | 218 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3264 | 0.050 |
Why?
|
Daunorubicin | 1 | 2020 | 153 | 0.050 |
Why?
|
Stem Cell Transplantation | 2 | 2022 | 1635 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2023 | 72448 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6274 | 0.050 |
Why?
|
Acetates | 1 | 2020 | 307 | 0.050 |
Why?
|
Bone and Bones | 1 | 2010 | 2567 | 0.050 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 2 | 2010 | 30 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8801 | 0.050 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2022 | 716 | 0.050 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 422 | 0.050 |
Why?
|
Cell Membrane | 1 | 2009 | 3879 | 0.040 |
Why?
|
Adrenal Insufficiency | 1 | 2020 | 171 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11238 | 0.040 |
Why?
|
Asparaginase | 1 | 2020 | 222 | 0.040 |
Why?
|
Off-Label Use | 1 | 2020 | 185 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2006 | 1887 | 0.040 |
Why?
|
Down-Regulation | 2 | 2020 | 3070 | 0.040 |
Why?
|
Erythroid Precursor Cells | 1 | 2019 | 224 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3894 | 0.040 |
Why?
|
Homeostasis | 1 | 2009 | 3328 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2019 | 266 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 689 | 0.040 |
Why?
|
Bone Remodeling | 1 | 2022 | 588 | 0.040 |
Why?
|
Vincristine | 1 | 2020 | 1038 | 0.040 |
Why?
|
Lysophosphatidylcholines | 1 | 2017 | 81 | 0.040 |
Why?
|
Neurons | 3 | 2019 | 9371 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 995 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2022 | 628 | 0.040 |
Why?
|
Milk Proteins | 1 | 2017 | 163 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 234 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2020 | 691 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 960 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1249 | 0.040 |
Why?
|
RNA, Guide | 1 | 2019 | 297 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2009 | 3014 | 0.040 |
Why?
|
Graft Survival | 2 | 2019 | 3753 | 0.040 |
Why?
|
Graft Rejection | 1 | 2010 | 4395 | 0.040 |
Why?
|
Benzamides | 1 | 2022 | 1389 | 0.040 |
Why?
|
Goals | 1 | 2021 | 651 | 0.040 |
Why?
|
Lymphoproliferative Disorders | 1 | 2019 | 539 | 0.040 |
Why?
|
Oligodendroglia | 1 | 2019 | 512 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 807 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4560 | 0.040 |
Why?
|
Visual Pathways | 1 | 2020 | 584 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1702 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2072 | 0.040 |
Why?
|
Young Adult | 2 | 2020 | 56140 | 0.030 |
Why?
|
Recurrence | 2 | 2022 | 8238 | 0.030 |
Why?
|
Prednisone | 1 | 2020 | 1548 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 983 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13219 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1120 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8560 | 0.030 |
Why?
|
Immunization | 1 | 2019 | 1276 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2020 | 2200 | 0.030 |
Why?
|
Peripheral Nervous System | 1 | 2015 | 142 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16726 | 0.030 |
Why?
|
Quinazolines | 1 | 2020 | 1406 | 0.030 |
Why?
|
Colorimetry | 1 | 2013 | 135 | 0.030 |
Why?
|
Spectrophotometry | 1 | 2013 | 373 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9544 | 0.030 |
Why?
|
Liver | 1 | 2009 | 7588 | 0.030 |
Why?
|
Motor Activity | 1 | 2004 | 2774 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1593 | 0.030 |
Why?
|
Endocytosis | 1 | 2018 | 1006 | 0.030 |
Why?
|
Adult | 4 | 2021 | 212237 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9730 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2018 | 2599 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 5046 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1726 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2551 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1629 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5995 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1841 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1681 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2095 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6238 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1720 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1356 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Astrocytes | 1 | 2019 | 1233 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13635 | 0.030 |
Why?
|
Phagocytosis | 1 | 2017 | 1580 | 0.030 |
Why?
|
Autoimmunity | 1 | 2019 | 1328 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7059 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2019 | 14154 | 0.030 |
Why?
|
Drug Discovery | 1 | 2019 | 1054 | 0.030 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2010 | 28 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 1474 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3569 | 0.030 |
Why?
|
Animal Structures | 1 | 2010 | 24 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2015 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2985 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 117 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4813 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 128 | 0.020 |
Why?
|
Cytoprotection | 1 | 2010 | 215 | 0.020 |
Why?
|
Sulfotransferases | 1 | 2010 | 143 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2589 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2697 | 0.020 |
Why?
|
Myelopoiesis | 1 | 2010 | 129 | 0.020 |
Why?
|
Lymphopoiesis | 1 | 2010 | 134 | 0.020 |
Why?
|
Silver Nitrate | 1 | 2009 | 12 | 0.020 |
Why?
|
Middle East | 1 | 2009 | 200 | 0.020 |
Why?
|
Antibodies | 1 | 2017 | 2426 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2010 | 299 | 0.020 |
Why?
|
Medical Oncology | 1 | 2021 | 2121 | 0.020 |
Why?
|
Rats | 2 | 2020 | 24794 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 7015 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2129 | 0.020 |
Why?
|
Health Status | 1 | 2022 | 4005 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2019 | 13203 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3175 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 443 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2009 | 701 | 0.020 |
Why?
|
Nerve Net | 1 | 2020 | 2136 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2009 | 663 | 0.020 |
Why?
|
Cattle | 1 | 2013 | 3952 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2009 | 293 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2200 | 0.020 |
Why?
|
Exocytosis | 1 | 2009 | 362 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2015 | 894 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 641 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6732 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 2579 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3800 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 13171 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1201 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2010 | 519 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4693 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3370 | 0.020 |
Why?
|
Signal Transduction | 1 | 2010 | 23705 | 0.020 |
Why?
|
Axons | 1 | 2015 | 1728 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6868 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3816 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5190 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2010 | 702 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 725 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4291 | 0.020 |
Why?
|
Pediatrics | 1 | 2021 | 3551 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 2034 | 0.020 |
Why?
|
Nitriles | 1 | 2010 | 943 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 13209 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8042 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 2787 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1037 | 0.020 |
Why?
|
Electroencephalography | 1 | 2019 | 5803 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10285 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2004 | 823 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5933 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 979 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10600 | 0.010 |
Why?
|
Luciferases | 1 | 2004 | 749 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9494 | 0.010 |
Why?
|
Adenoviridae | 1 | 2007 | 1126 | 0.010 |
Why?
|
Cysteine | 1 | 2007 | 867 | 0.010 |
Why?
|
Muscles | 1 | 2007 | 1557 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 23385 | 0.010 |
Why?
|
Isoenzymes | 1 | 2007 | 1799 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15606 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7445 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 2051 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 11942 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21804 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4149 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2451 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8647 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 51354 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2009 | 2810 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2806 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4285 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4887 | 0.010 |
Why?
|
Stem Cells | 1 | 2010 | 3561 | 0.010 |
Why?
|
Blotting, Western | 1 | 2004 | 5369 | 0.010 |
Why?
|
Sepsis | 1 | 2010 | 2463 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10513 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5407 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18583 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12285 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 8028 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20761 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7877 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40889 | 0.000 |
Why?
|